Exclusive

Publication

Byline

Singapore Clinical Trial: A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus Adjuvant Chemotherapy Versus Placebo Plus Adjuvant Chemotherapy in Stage IB-IIIA NSCLC Patients with Uncommon EGFR Mutations Following Complete Tumor Resection (REZILIENT4)

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Randomized, Placebo-Controlled, Double-Blind, Multi-Center Phase 3 Study of Zipalertinib Plus A... Read More


Singapore Clinical Trial: Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvant monotherapy compared with standard of care in patients with early-stage, resectable non-small cell lung cancer (Stage II-IIIB) harboring tyrosine kinase domain activating HER2 mutations

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'Beamion LUNG-3: A randomized, controlled, multi-center trial evaluating zongertinib as an adjuvan... Read More


Singapore Clinical Trial: A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the effects of oral TRPC6 inhibitor BI 764198 taken over a 104 week treatment period in adult and adolescent participants with primary focal segmental glomerulosclerosis (pFSGS) or genetic FSGS related to TRPC6 gene variants

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A multicentre, randomised, double-blind, parallel group, placebo-controlled trial to assess the e... Read More


Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investiga... Read More


Singapore Clinical Trial: A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investigate the efficacy and safety of lunsekimig in adult participants with inadequately controlled chronic obstructive pulmonary disease (COPD) characterized by an eosinophilic phenotype

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 2b/Phase 3, randomized, double-blind, placebo-controlled, multicenter study, to investiga... Read More


Singapore Clinical Trial: A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of LY4167586 in Participants with Obesity or Overweight who are Otherwise Healthy.

Singapore, March 31 -- The Health Sciences Authority received information related to the study titled 'A Phase 1, Randomized, Placebo-Controlled, Single Ascending Dose-Escalation Study to Investigate ... Read More


'Redemption is here': Dino Melaye explains how ADC will defeat Tinubu in 2027

Nigeria, March 31 -- A former Kogi West senator, Dino Melaye, has argued that the opposition African Democratic Congress (ADC) will defeat President Bola Tinubu in the 2027 presidential election in Ni... Read More


Mercedes-Benz CLA Electric set to launch in India on April 24: expected price, features and battery pack

India, March 31 -- German automaker Mercedes-Benz is set to launch its entry-level electric sedan, the CLA electric, in India on April 24. This is the first time that the CLA will be launched in an el... Read More


Israel Passes Death Penalty Law for Palestinians

Afghanistan, March 31 -- Israel's parliament has approved a controversial new law that imposes the death penalty by default on Palestinians convicted of deadly attacks, drawing sharp international cri... Read More


Bhumi: వయసు పెరుగుతోంది, అందుకే నా శరీరంపై ఫోకస్ పెట్టాను.. వెయిట్ లాస్ ట్రోల్స్‌పై స్టార్ హీరోయిన్ భూమి కామెంట్స్

భారతదేశం, మార్చి 31 -- బాలీవుడ్ వెర్సటైల్ హీరోయిన్ భూమి పెడ్నేకర్ తన కెరీర్ ఆరంభం నుంచి బాడీ ట్రాన్స్‌ఫార్మేషన్ విషయంలో వార్తల్లో నిలుస్తూనే ఉన్నారు. తొలి సినిమా 'దమ్ లగా కే హయిషా' కోసం భారీగా బరువు ప... Read More